Kevin D. Brandt
Net Worth
Last updated:
What is Kevin D. Brandt net worth?
The estimated net worth of Mr. Kevin D. Brandt is at least $2,357,532 as of 17 Nov 2023. He owns shares worth $530,309 as insider, has earned $11,233 from insider trading and has received compensation worth at least $1,815,990 in Xtant Medical Holdings, Inc..
What is the salary of Kevin D. Brandt?
Mr. Kevin D. Brandt salary is $605,330 per year as Senior Vice President & Chief Commercial Officer in Xtant Medical Holdings, Inc..
How old is Kevin D. Brandt?
Mr. Kevin D. Brandt is 59 years old, born in 1966.
What stocks does Kevin D. Brandt currently own?
As insider, Mr. Kevin D. Brandt owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | Senior Vice President & Chief Commercial Officer | 815,860 | $0.65 | $530,309 |
What does Xtant Medical Holdings, Inc. do?
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Kevin D. Brandt insider trading
Xtant Medical Holdings, Inc.
Mr. Kevin D. Brandt has made 2 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he purchased 41,670 units of XTNT stock worth $49,837 on 17 Nov 2023.
The largest trade he's ever made was exercising 41,670 units of XTNT stock on 17 Nov 2023. As of 17 Nov 2023 he still owns at least 815,860 units of XTNT stock.
Xtant Medical Holdings key executives
Xtant Medical Holdings, Inc. executives and other stock owners filed with the SEC:
- Mr. Kevin D. Brandt (59) Senior Vice President & Chief Commercial Officer
- Mr. Sean E. Browne (59) Pres, Chief Executive Officer & Director